feed,title,long_url,short_url
SeekingAlpha,Brunswick Is Still On Track To Achieve 2022 Financial Targets,https://seekingalpha.com/article/4363944,
SeekingAlpha,Gilead Sciences: Remdesivir Remains A Distraction,https://seekingalpha.com/article/4363942,
SeekingAlpha,The Chemist's Quality Closed-End Fund Report: July 2020,https://seekingalpha.com/article/4363945,
